These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30936486)

  • 21. Lactoferrin for prevention of common viral infections.
    Wakabayashi H; Oda H; Yamauchi K; Abe F
    J Infect Chemother; 2014 Nov; 20(11):666-71. PubMed ID: 25182867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enteric viruses in HIV-1 seropositive and HIV-1 seronegative children with diarrheal diseases in Brazil.
    Portes SAR; Carvalho-Costa FA; Rocha MS; Fumian TM; Maranhão AG; de Assis RM; Xavier MDPTP; Rocha MS; Miagostovich MP; Leite JPG; Volotão EM
    PLoS One; 2017; 12(8):e0183196. PubMed ID: 28854225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Norovirus encounters in the gut: multifaceted interactions and disease outcomes.
    Hassan E; Baldridge MT
    Mucosal Immunol; 2019 Nov; 12(6):1259-1267. PubMed ID: 31501514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Norovirus in immunocompromised patients.
    Atmar J; Mullen E
    Oncol Nurs Forum; 2013 Sep; 40(5):434-6. PubMed ID: 23989016
    [No Abstract]   [Full Text] [Related]  

  • 25. Persistent enteric murine norovirus infection is associated with functionally suboptimal virus-specific CD8 T cell responses.
    Tomov VT; Osborne LC; Dolfi DV; Sonnenberg GF; Monticelli LA; Mansfield K; Virgin HW; Artis D; Wherry EJ
    J Virol; 2013 Jun; 87(12):7015-31. PubMed ID: 23596300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses.
    Mumphrey SM; Changotra H; Moore TN; Heimann-Nichols ER; Wobus CE; Reilly MJ; Moghadamfalahi M; Shukla D; Karst SM
    J Virol; 2007 Apr; 81(7):3251-63. PubMed ID: 17229692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Within-host evolution results in antigenically distinct GII.4 noroviruses.
    Debbink K; Lindesmith LC; Ferris MT; Swanstrom J; Beltramello M; Corti D; Lanzavecchia A; Baric RS
    J Virol; 2014 Jul; 88(13):7244-55. PubMed ID: 24648459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go?
    Ramani S; Estes MK; Atmar RL
    PLoS Pathog; 2016 Apr; 12(4):e1005334. PubMed ID: 27115358
    [No Abstract]   [Full Text] [Related]  

  • 29. Caspase-mediated cleavage of murine norovirus NS1/2 potentiates apoptosis and is required for persistent infection of intestinal epithelial cells.
    Robinson BA; Van Winkle JA; McCune BT; Peters AM; Nice TJ
    PLoS Pathog; 2019 Jul; 15(7):e1007940. PubMed ID: 31329638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between noroviruses, the host, and the microbiota.
    Walker FC; Baldridge MT
    Curr Opin Virol; 2019 Aug; 37():1-9. PubMed ID: 31096124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe viral gastroenteritis in children after suboptimal rotavirus immunization in Taiwan.
    Chen SY; Tsai CN; Chen CL; Chao HC; Lee YS; Lai MW; Chen CC; Huang WL; Chiu CH
    Pediatr Infect Dis J; 2013 Dec; 32(12):1335-9. PubMed ID: 23881091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insights into the global burden of noroviruses and opportunities for prevention.
    Hall AJ; Glass RI; Parashar UD
    Expert Rev Vaccines; 2016 Aug; 15(8):949-51. PubMed ID: 27142965
    [No Abstract]   [Full Text] [Related]  

  • 33. Intestinal intraepithelial lymphocyte activation promotes innate antiviral resistance.
    Swamy M; Abeler-Dörner L; Chettle J; Mahlakõiv T; Goubau D; Chakravarty P; Ramsay G; Reis e Sousa C; Staeheli P; Blacklaws BA; Heeney JL; Hayday AC
    Nat Commun; 2015 May; 6():7090. PubMed ID: 25987506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nlrp6 regulates intestinal antiviral innate immunity.
    Wang P; Zhu S; Yang L; Cui S; Pan W; Jackson R; Zheng Y; Rongvaux A; Sun Q; Yang G; Gao S; Lin R; You F; Flavell R; Fikrig E
    Science; 2015 Nov; 350(6262):826-30. PubMed ID: 26494172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions.
    Pearson JA; Tai N; Ekanayake-Alper DK; Peng J; Hu Y; Hager K; Compton S; Wong FS; Smith PC; Wen L
    Front Immunol; 2019; 10():2654. PubMed ID: 31798584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunology. Interfering with interferons.
    Wilks J; Golovkina T
    Science; 2015 Jan; 347(6219):233-4. PubMed ID: 25593173
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevalence and clinical impact of norovirus fecal shedding in children with inherited immune deficiencies.
    Frange P; Touzot F; Debré M; Héritier S; Leruez-Ville M; Cros G; Rouzioux C; Blanche S; Fischer A; Avettand-Fenoël V
    J Infect Dis; 2012 Oct; 206(8):1269-74. PubMed ID: 22872736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-exposure antiviral treatment of norovirus infections effectively protects against diarrhea and reduces virus shedding in the stool in a mortality mouse model.
    Rocha-Pereira J; Kolawole AO; Verbeken E; Wobus CE; Neyts J
    Antiviral Res; 2016 Aug; 132():76-84. PubMed ID: 27252124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Norovirus interactions with the commensal microbiota.
    Sullender ME; Baldridge MT
    PLoS Pathog; 2018 Sep; 14(9):e1007183. PubMed ID: 30188944
    [No Abstract]   [Full Text] [Related]  

  • 40. Mucosal Antibodies Induced by Intranasal but Not Intramuscular Immunization Block Norovirus GII.4 Virus-Like Particle Receptor Binding.
    Tamminen K; Malm M; Vesikari T; Blazevic V
    Viral Immunol; 2016 Jun; 29(5):315-9. PubMed ID: 27135874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.